Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

CHU Brugmann, Brussels

Jan Palfijn Ziekenhuis, Merksem

Leiden University Medical Centre, Leiden

University Hospital, Leuven

Universiteit Hasselt, Diepenbeek

Radboud University, Nijmegen

Free University of Berlin, Berlin

Klinikum Eilbek, Hamburg

Rheumazentrum Ruhrgebiet, Herne

Klinikum der Universität Munster, Münster

Universitaetsklinik Koeln, Cologne

Universitaetsklinikum Frankfurt, Frankfurt

Universitaet Heidelberg, Heidelberg

University of Munich, Munich

Friedrich-Alexander University, Erlangen, Nuremberg

Capio Franz von Prümmer Klinik, Bad Brückenau

The Arthritis Research Centre of Canada, Vancouver

Victoria

Nexus Clinical Research, St. John's

Burlington Rheumatology and Osteoporosis Clinic, Burlington

MAC Research Inc., Hamilton

K-W Musculoskeletal Research Inc., Kitchener

Credit Valley Rheumatology, Mississauga

Arthritis Program Research Group Inc, Newmarket

Rheumatology Research Associates, Ottawa

Center for Prognosis Studies in the Rheumatic Diseases University Health Network, Toronto Western Hospital, Toronto

Mount Sinai Hospital, Toronto

Probity Medical, Waterloo

Clinical Research and Arthritis Centre, Windsor

West Island Rheumatology Research Associates, Pointe-Claire

Saskatoon Osteoporosis Center, Saskatoon

Universitaet Leipzig, Leipzig

Universitaetsklinikum Leipzig, Leipzig

Hagaziekenhuis, The Hague

Hope Hospital, Salford

Haywood Hospital, Stoke-on-Trent

Chapel Allerton Hospital, Leeds

Freeman Hospital, Newcastle upon Tyne